Back to results
US 2026/0227388 A1Published application
Fret-based microarray screening platforms
AssigneeThe General Hospital Corporation
InventorsRalph Mazitschek, Neil Connor Payne
Life of this patent
Estimating the term…
Abstract
The present disclosure provides FRET-based microarray platforms, reagents, and methods.
Claims20
A method for detecting an interaction of a target molecule and a ligand molecule, the method comprising:
- (i) treating a surface modified with a target molecule, wherein either the surface or the target molecule is further modified with a FRET acceptor moiety, with a ligand molecule, wherein the ligand molecule is modified with a FRET donor moiety;
- and
- (ii) exciting the surface with a light of a wavelength capable of being absorbed by the FRET donor moiety, waiting an amount of time sufficient for energy transfer from the FRET donor moiety to the FRET acceptor moiety, and detecting a light of a wavelength emitted by the FRET acceptor moiety by a fluorescence imaging technique.
A method for detecting an interaction of a target molecule and a ligand molecule, the method comprising:
- (i) treating a surface modified with a target molecule, wherein either the surface or the target molecule is further modified with a FRET donor moiety,
- with a ligand molecule, wherein the ligand molecule is modified a FRET acceptor moiety;
- and
- (ii) exciting the surface with a light of a wavelength capable of being absorbed by the FRET donor moiety, waiting an amount of time sufficient for energy transfer from the FRET donor moiety to the FRET acceptor moiety, and detecting a light of a wavelength emitted by the FRET acceptor moiety by a fluorescence imaging technique.
1 more element
A method of identifying a compound that modulates a protein of interest, the method comprising:
- (i) treating a surface modified with a target molecule, wherein either the surface or the target molecule is further modified with a FRET acceptor moiety,
- with a protein of interest, wherein the protein of interest is modified with a FRET donor moiety;
- (ii) exciting the surface with a light of a wavelength capable of being absorbed by the FRET donor moiety, waiting an amount of time sufficient for energy transfer from the FRET donor moiety to the FRET acceptor moiety, and detecting a light of a wavelength emitted by the FRET acceptor moiety by a fluorescence imaging technique;
- (iii) treating the surface with a test compound;
- (iv) after (iii), detecting a light of a wavelength emitted by the FRET acceptor moiety by the fluorescence imaging technique;
- and
- (v) determining whether an intensity of fluorescence detected from the FRET acceptor moiety in step (iv) is decreased compared to an intensity of fluorescence detected from the FRET acceptor moiety in step (ii),
- wherein said decrease in fluorescence intensity in an indication that the test compound is a modulator the protein of interest.
5 more elements
Dependencies are inferred from the claim text.